Cargando…
Suppression of Tumourigenicity 2 in Heart Failure With Preserved Ejection Fraction
Heart failure (HF), with steadily increasing incidence rates and mortality in an ageing population, represents a major challenge. Evidence suggests that more than half of all patients with a diagnosis of HF suffer from HF with preserved ejection fraction (HFpEF). Emerging novel biomarkers to improve...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Radcliffe Cardiology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111301/ https://www.ncbi.nlm.nih.gov/pubmed/32257387 http://dx.doi.org/10.15420/cfr.2019.10 |